| AGAP1 (2q37.2) / MYH9 (22q12.3) | ALK (2p23.2) / MYH9 (22q12.3) | CHMP2B (3p11.2) / MYH9 (22q12.3) |
|
EEF1G (11q12.3) / MYH9 (22q12.3) | FOXRED2 (22q12.3) / MYH9 (22q12.3) | GALNT10 (5q33.2) / MYH9 (22q12.3) |
|
IPO7 (11p15.4) / MYH9 (22q12.3) | IRX3 (16q12.2) / MYH9 (22q12.3) | MYH9 (22q12.3) / ALK (2p23.2) |
|
MYH9 (22q12.3) / ATP6V0B (1p34.1) | MYH9 (22q12.3) / C20orf96 (20p13) | MYH9 (22q12.3) / CD81 (11p15.5) |
|
MYH9 (22q12.3) / CFDP1 (16q23.1) | MYH9 (22q12.3) / CHCHD3 (7q32.3) | MYH9 (22q12.3) / EIF3D (22q12.3) |
|
MYH9 (22q12.3) / FAM160A2 (11p15.4) | MYH9 (22q12.3) / FLNA (Xq28) | MYH9 (22q12.3) / FOXRED2 (22q12.3) |
|
MYH9 (22q12.3) / JUP (17q21.2) | MYH9 (22q12.3) / MYH9 (22q12.3) | MYH9 (22q12.3) / NCL (2q37.1) |
|
MYH9 (22q12.3) / NUCB1 (19q13.33) | MYH9 (22q12.3) / PITHD1 (1p36.11) | MYH9 (22q12.3) / PML (15q24.1) |
|
MYH9 (22q12.3) / PSME1 (14q12) | MYH9 (22q12.3) / RAPGEF1 (9q34.13) | MYH9 (22q12.3) / SERPINA1 (14q32.13) |
|
MYH9 (22q12.3) / SLC44A4 (6p21.33) | MYH9 (22q12.3) / TXN2 (22q12.3) | MYH9 (22q12.3) / USP6 (17p13.2) |
|
OS9 (12q13.3) / MYH9 (22q12.3) | PSMA1 (11p15.2) / MYH9 (22q12.3) | PTMS (12p13.31) / MYH9 (22q12.3) |
|
RAB2A (8q12.1) / MYH9 (22q12.3) | RPL11 (1p36.11) / MYH9 (22q12.3) | RPL13 (16q24.3) / MYH9 (22q12.3) |
|
RPS20 (8q12.1) / MYH9 (22q12.3) | SECISBP2 (9q22.2) / MYH9 (22q12.3) | SMR3B (4q13.3) / MYH9 (22q12.3) |
|
TGFBI (5q31.1) / MYH9 (22q12.3) | TPM2 (9p13.3) / MYH9 (22q12.3) | UBTF (17q21.31) / MYH9 (22q12.3) |
|
WDR60 (7q36.3) / MYH9 (22q12.3) |
Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. |
Kelley MJ, Jawien W, Ortel TL, Korczak JF |
Nature genetics. 2000 ; 26 (1) : 106-108. |
PMID 10973260 |
|
Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. |
Kunishima S, Matsushita T, Kojima T, Amemiya N, Choi YM, Hosaka N, Inoue M, Jung Y, Mamiya S, Matsumoto K, Miyajima Y, Zhang G, Ruan C, Saito K, Song KS, Yoon HJ, Kamiya T, Saito H |
Journal of human genetics. 2001 ; 46 (12) : 722-729. |
PMID 11776386 |
|
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. |
Lalwani AK, Goldstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN |
American journal of human genetics. 2000 ; 67 (5) : 1121-1128. |
PMID 11023810 |
|
Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. |
Lamant L, Gascoyne RD, Duplantier MM, Armstrong F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J, Delsol G, Espinos E |
Genes, chromosomes & cancer. 2003 ; 37 (4) : 427-432. |
PMID 12800156 |
|
Five (un)easy pieces: the MYH9-related giant platelet syndromes. |
Martignetti J |
Haematologica. 2002 ; 87 (9) : 897-898. |
PMID 12217798 |
|
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. |
Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA |
Nature genetics. 2000 ; 26 (1) : 103-105. |
PMID 10973259 |
|
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. |
Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A |
Medicine. 2003 ; 82 (3) : 203-215. |
PMID 12792306 |
|